Latest News of SNY
Sanofi plans to change hospital drug-discount program, WSJ reports
Sanofi plans to modify its discount policy for U.S. hospitals serving low-income patients. The new plan, effective next year, requires hospitals to provide specific information for 340B program discou...
Love Is Blind's Stacy Snyder Recalls 'Living a Double Life' While Hiding Relationship with a Woman in Her Early 20s
Reality star Danielle Ruhl, from Love Is Blind season 5, shared her experience publicly coming out as queer on a podcast. She revealed her past relationship with a woman and the challenges of sharing ...
Sanofi (SNY) Q3 2024 Earnings Call Transcript
Sanofi reported strong growth in Q3 2024 with a 16% increase in CER for total sales of 13.4 billion euros. Dupixent and Vaccine business showed robust growth. Opella deal was discussed, with cash proc...
-
Eli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's Dupixent
By Yahoo! Finance | 4 weeks agoEli Lilly's Phase 3b ADapt study on Ebglyss for atopic dermatitis showed significant improvements in skin and itch, especially for patients previously treated with Dupixent. Results include a high per...
-
Sanofi Q3 earnings beat market view, boosted by vaccine sales
By Reuters | 4 weeks ago(Reuters) - French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, helped by earlier-than-anticipated sales of seasonal vaccines.Quarte...
-
Temenos AG (TMSNY) Q3 2024 Earnings Call Highlights: Strong ARR Growth Amid Sales Challenges
By Yahoo! Finance | 4 weeks agoTemenos aims to enhance sales operations, address regional challenges, and invest in product and technology. The efficiency program targets cost savings, balancing growth and profitability. Europe's p...
-
France to take stake in Sanofi unit to quell backlash over sale to US firm
By The Guardian | 1 month ago -
Sanofi enters exclusive talks with CD&R for Opella sale
By Reuters | 1 month agoPARIS (Reuters) -Sanofi said on Monday it had entered exclusive talks for the sale of a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & ...
-
CD&R Nears Sanofi OTC Deal After Signing With Government
By Yahoo! Finance | 1 month agoClayton Dubilier & Rice is close to acquiring Sanofi's consumer health unit, with social commitments made to the French government. The deal includes job, investment, and production pledges. State-own...
-
Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI
By Yahoo! Finance | 1 month agoFrance will acquire a stake in Sanofi's Opella through Public Investment Bank (BPI), while U.S. private equity firm CD&R will take a 51% stake....
-
Snyder throws for 3 TDs, runs for game-winner in Eastern Michigan's 38-34 victory over Chippewas
By CBS News | 1 month agoCole Snyder led Eastern Michigan to a thrilling 38-34 comeback victory over Central Michigan, throwing for three touchdowns and rushing for the game-winning score late in the fourth quarter. The Eagle...
-
Sanofi and Orano Med link for radioligand therapy development
By Yahoo! Finance | 1 month agoSanofi partners with Orano Med to advance radioligand therapies for rare cancers. The €300m investment will support the development of lead-212 based therapies, strengthening Orano Med's pipeline. T...
-
PAI Partners Submits Improved Bid on Sanofi's Consumer Unit
By MarketWatch | 1 month agoPAI Partners raised its bid for Sanofi's consumer health business to reenter the race for a major deal. The offer includes plans to maintain operations in France, surpassing rival CD&R's bid....
-
PAI Partners to Raise Offer for Sanofi's Consumer Unit
By Yahoo! Finance | 1 month agoPAI Partners has raised its bid for Sanofi's consumer health business by €200 million and pledged to maintain French headquarters and jobs. The improved offer is valid until Sunday. The French gover...
-
Goldman, Citi Among 22 Banks on CD&R's Buyout of Sanofi Unit
By Yahoo! Finance | 1 month agoGoldman Sachs, Citigroup, and 20 other banks are set to provide financing for Clayton Dubilier & Rice's stake in Sanofi's consumer health division. The deal includes €8.65 billion in loans and bonds...